Cleveland BioLabs, Inc. is a biotech company specializing in the development of innovative drugs for biodefense, tissue protection, and cancer treatment. The company's pipeline includes protectans and curaxins, two families of compounds with exciting potential in the pharmaceutical industry. Protectans are being developed as drug candidates to protect healthy tissues from acute stresses such as chemotherapy and ischemia, while curaxins are being developed as anticancer agents that could be used as stand-alone treatments or in combination with other therapies. Cleveland BioLabs is rapidly advancing its research in these areas and is poised to make a significant impact in the field of biotechnology.